EPA/DHA Vegetarian

• Calories

  10 Calories

• Total Fat

  1 Gram

• Eicosapentaenoic Acid

  155 mg

  Ingredient research · EPA

  EPA is a long-chain omega-3 fatty acid that helps generate signaling molecules involved in inflammation and vascular function. Supplementation can lower elevated triglycerides, while highly purified prescription EPA can reduce cardiovascular events in some high-risk adults; these findings do not necessarily extend to mixed EPA-DHA fish-oil products.

  • Supports triglyceride markers.
  • Supports selected cholesterol markers.
  • Supports blood pressure and vascular function.
  • Supports systemic inflammation markers.

  Top References

  • Comparing the serum TAG response to high-dose supplementation of either DHA or EPA among individuals with increased cardiovascular risk: the ComparED study
  • The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials
  • Omega-3 Eicosapentaenoic Acid (EPA) Rich Extract from the Microalga Nannochloropsis Decreases Cholesterol in Healthy Individuals: A Double-Blind, Randomized, Placebo-Controlled, Three-Month Supplementation Study
  • Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus.
  • Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials
  • Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on C-Reactive Protein, Interleukin 6 and Tumor Necrosis Factor α: A Meta-Analysis
  • Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis.

• Docosahexaenoic Acid

  310 mg

  Ingredient research · DHA

  DHA is a long-chain omega-3 fatty acid and a structural component of the brain and retina, making it especially important during pregnancy and infancy. Supplementation can help maintain DHA status when intake is low, may support fetal and infant brain and visual development, and can lower blood triglycerides; other cardiovascular effects are shared with EPA.

  • Supports cholesterol and triglyceride measures.
  • Supports liver-fat measures in children and adolescents with nonalcoholic fatty liver disease.
  • Supports blood-pressure and vascular-function measures.
  • Supports inflammatory and oxidative-stress markers.

  Top References

  • Comparing the serum TAG response to high-dose supplementation of either DHA or EPA among individuals with increased cardiovascular risk: the ComparED study
  • Docosahexaenoic Acid Supplementation, Vascular Function and Risk Factors for Cardiovascular Disease: A Randomized Controlled Trial in Young Adults
  • Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
  • A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
  • Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus.
  • Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials
  • Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on C-Reactive Protein, Interleukin 6 and Tumor Necrosis Factor α: A Meta-Analysis
  • Improvement of Nrf2 gene expression and antioxidant status in patients with type 2 diabetes mellitus after supplementation with omega-3 polyunsaturated fatty acids: a double-blind randomised placebo-controlled clinical trial.

Ranking